Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer

Su Ling Tseng, Jyh Cherng Yu, Chung Tai Yue, Shu Fen Chang, Tzu Ming Chang, Cheng-Wen Wu Lee, Chen Yang Shen*

*Corresponding author for this work

研究成果: Article同行評審

25 引文 斯高帕斯(Scopus)

摘要

Cells with abnormal TP53 lose cell cycle checkpoints, resulting in genomic instability and neoplastic transformation. However, the evidence linking the tumor-specific targets of genomic alteration to an abnormal TP53 is limited. The present study tested the hypothesis that TP53 abnormalities are correlated with an increased frequency of deletion of breast cancer susceptibility loci (17q and 13q) in breast carcinomas. Tumors from 90 patients were examined for TP53 abnormality and loss of heterozygosity (LOH) at 11 loci on 17q (17q11.2-21) and 13q (13q12-14), including the loci for BRCA1 and BRCA2. A higher frequency of LOH was consistently found at 17q or 13q loci in tumors with an abnormal TP53. The increased LOH in relation to TP53 abnormality was statistically significant at the BRCA1, D17S588, and D13S267 loci (P < 0.05) but not at the locus for 8RCA2 (P = 0.64). These observations imply a possible link between an abnormal TP53 and specific genomic deletions of breast cancer susceptibility loci, which may provide clues to the role of TP53 during breast tumorigenesis.

原文English
頁(從 - 到)377-382
頁數6
期刊Genes Chromosomes and Cancer
20
發行號4
DOIs
出版狀態Published - 1 十二月 1997

指紋 深入研究「Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer」主題。共同形成了獨特的指紋。

引用此